receptor) (Alkhatib et al., 1996; Choe et al., 1996; Deng et al., 1996; 48 Doranz et al., 1996; Dragic et al., 1996; Feng et al., 1996; Trkola 49 et al., 1996; Wu et al., 1996) . About 20 G-protein-coupled receptors to determine whether the differences in frequency between the 2 185 groups of patients were statistically significant (isolates with strong 186 CCR5 and CXCR4 prediction, respectively).
187
The Benjamini-Hochberg method has been used to iden-188 tify results that were statistically significant in the presence of 189 multiple-hypothesis testing (Benjamini and Hochberg, 1995) . A 190 false discovery rate of 0.05 was used to determine statistical sig- at a false discovery rate of 0.05 (Benjamini and Hochberg, 1995) .
206
Using again the nonparametric Mann-Whitney U tests, we com- 
Results and discussion

211
The genotypic algorithms built from B-subtype virus data are 212 questioned whether they correctly predict the tropism of non-B 213 viruses (Garrido et al., 2008) , despite recent observations suggest-214 ing that they performed well for predicting the tropism of HIV-1 215 clade C virus (Raymond et al., 2010) . Moreover, a study compar-216 ing the predictive performance of Geno2Pheno, PSSM and other 217 methods against the first-generation Trofile ® assay (validated for 218 HIV-1 tropism determination), concluded that the concordance 219 being as high as 91% (Raymond et al., 2008 (with FPR ≥80%), and 101 CXCR4-using (with FPR ≤5%). The predic-239 tion of co-receptor usage was fully confirmed using both Fortinbras 240 PSSM algorithm, and the "net charge" and "11/25" rules (Table 1) 241 (Vandekerckhove et al., 2011) . Thus, these 3 interpretation methods
242
for tropism-prediction provide superimposable results.
243
Previous studies have shown that CXCR4-using viruses were 
249
By evaluating the V3-loop sequences, we have identified 11 250 amino acids at specific V3 positions whose prevalence was sig-251 nificantly higher in CCR5-using than in CXCR4-using viruses (P 252 values from 1.40E−30 to 1.66E−2) (Fig. 1) . All of them (D25D 253 and S11S, and T2V, N5N, N6N, N7N, K10ET, P16P, G24T, D29N 254 and Q32E) had a prevalence ≥10% (ranging from 12.2% to 100%) 255 in CCR5-using viruses. We also identified 46 amino acids at spe-256 cific V3 positions whose prevalence was significantly higher in 257 CXCR4-using than in CCR5-using viruses, suggesting their asso-258 ciation with CXCR4-usage (P values from 2.34E−38 to 4.49E−2).
259
Among them, 18 (S11R and D25KRQ, and N5G, T8KR, K10R, S11G, showed that the wild-type amino acid at positions 11 and 272 25 (S11S and D25D) were significantly associated with CCR5-273 usage (P = 6.77E−10; ϕ = 0.41), respectively, while S11GR and 274 D25KRQ mutations were significantly associated with CXCR4 usage 275 (P = 3.36E−4; ϕ = 0.31) (Fig. 1) . Among the other mutations found 276 at V3 position 25 of HIV-1 C-subtype, the prevalence of E (wild-277 type for B-subtype) was higher in CCR5-using than CXCR4-using 278 viruses (15.7% and 6.9%, respectively, P = 0.071). Conversely, the 279 mutations K, N, P, Q, R, T and V at position 25 were mainly found 280 in CXCR4-using viruses (1.2% in CCR5 versus 56.4% in CXCR4). Only glycine. This glycine is completely absent in all V3 sequences from 287 CCR5-using viruses, while it was observed in 12.8% of CXCR4-using 288 viruses (P = 4.74E−8) (Fig. 1) . When the position 11 was mutated 289 (47.5%) the corresponding virus was always CXCR4-using.
290
We also analyzed the V3 region encompassing the amino and C-subtypes (Back et al., 1994; Li et al., 2001; Losman et al., 1999; 297 Malenbaum et al., 2000; McCaffrey et al., 2004) . In our dataset,
298
N7K mutation was found only in CXCR4-using viruses (prevalence 299 7.9% in CXCR4-using versus 0% in CCR5-using viruses; P = 5.48E−6) 300 ( Fig. 1 ). This suggests that N7K can be a CXCR4 related marker also 301 in C-subtype. In addition, the loss of the N-linked glycosylation site 302 was observed in 1.6% of CCR5-and 20.8% of CXCR4-using viruses
303
(P < 0.001) ( Table 1 ) (Nabatov et al., 2004; Polzer et al., 2002) .
304
Considering the physical and chemical properties of CCR5-305 versus CXCR4-using viruses (Table 1) , the net charge of CCR5-using 306 viruses (mean 2.85, median 3.00, IQR 2.00-3.00) was significantly 307 lower than that observed in CXCR4-using viruses (mean 5.32, Frequencies of V3 signatures in HIV-1 CCR5-tropic isolates with FPR ≥80% by Geno2Pheno-algorithm prediction (dark gray) and HIV-1 CXCR4-tropic isolates with FPR ≤5% by Geno2Pheno-algorithm prediction (light gray). The analysis was performed in sequences derived from 356 patients, 255 reported as CCR5-tropic and 101 reported as CXCR4-tropic at genotypic test. The co-receptor usage of the sequences was confirmed using Fortinbras PSSM algorithm and the combination of criteria from the net charge and "11/25" rules. Statistically significant differences were assessed by chi-square tests of independence. P values were significant at a false-discovery rate of 0.05 following correction for multiple tests. *P < 0.05, **P ≤ 0.01, ***P ≤ 0.001. The codons with a black dot (22/29) were significant and confirmed also using a dataset of V3 sequences with phenotypic tropism determination (423 CCR5-and 48 CXCR4-using viruses, respectively). insertion was never found in CCR5-using viruses (Fig. 1) .
371
The high variability of the V3-loop is not surprising, since pos- F188LMV, A189G, N195QR, G220E, Q297L, and I332AF) (Fig. 2) (Table 2) . Specifically, the D25D V3 showed positive correla-
458
tions with several gp41 substitutions (A22V, R133M, E136G, N140L,
459
and N166Q) ( Table 2 ). All these mutations correlated with CCR5-460 usage and localized in gp41 ectodomain (Cheung et al., 2005;  versely, S11S V3 established a positive correlation with only one 464 gp41 mutation (S154K) localized in HR2 domain (Table 2 ). Among Frequencies of gp41 signatures in HIV-1 CCR5-tropic isolates with FPR ≥80% by Geno2Pheno algorithm prediction (dark gray) and HIV-1 CXCR4-tropic isolates with FPR ≤5% by Geno2Pheno-algorithm prediction (light gray). Among the 312 env sequences containing the V3 and gp41 encoding regions, both Geno2Pheno and PSSM algorithms, and the combination of criteria from the net charge and "11/25" rules, predicted 255 CCR5-using and 57 CXCR4-using viruses, respectively. Statistically significant differences were assessed by chi-square tests of independence. P values were significant at a false-discovery rate of 0.05 following correction for multiple tests. *P < 0.05, **P ≤ 0.01, ***P ≤ 0.001. The codons with a black dot were validated also using a dataset of gp41 sequences with phenotypic tropism determination (106 CCR5-and 19 CXCR4-using viruses, respectively): in 44/68 mutations identified using genotypic tropism prediction the trend of correlation with different co-receptor using was confirmed.
F20ILV V3 (P = 0.023; ϕ = 0.28) ( Table 2 ). Of note, F20ILV V3 were 468 found in 40% of patients with A30T gp41 , thus further supporting 469 that these variants are enough correlated with each other (Table 2) . Table 2) .
492
To further confirm the correlation among mutations V3 and CCR5-using and 19 CXCR4-using viruses, respectively), all with 496 a phenotypic tropic determination of viral tropism available.
497
In this set of sequences the correlation between the classical 498 D25D V3 and S11S V3 (P = 7.71E−7; ϕ = 0.41), and between D25KRQ V3 499 and S11GR V3 (P = 6.67E−12; ϕ = 0.78) was confirmed. Moreover, 500 other associations, involved F20ILV V3 and A189S gp41 (P = 8.00E−3; 501 ϕ = 1), A30T gp41 and D148E gp41 (P = 4.54E−3; ϕ = 0.48), N140IL gp41 502 and N166Q gp41 (P = 2.84E−2; ϕ = 0.29), N140IL gp41 and N136Q gp41 503 (P = 2.84E−2; ϕ = 0.29), S11S V3 and D148E gp41 (P = 3.16E−4; a Frequency was determined in 312 env-isolates from HIV-1 infected patients having FPR ≤5% and FPR ≥80%, using the Geno2Pheno algorithm. The co-receptor usage of the sequences was confirmed using Fortinbras PSSM algorithm and the combination of criteria from the net charge and "11/25" rules.
b Frequency was determined in 57 HIV-1 isolates reported as CXCR4-using by Geno2Pheno algorithm (FPR ≤5%) and by Fortinbras PSSM. c Percentages were calculated in patients with each specific env-mutation listed in the first column of the table. d Positive and negative correlations with ϕ > 0.10 and ϕ < −0.10, respectively are shown. e P values significant (P < 0.05) after correction for multiple hypothesis testing (Benjamini and Hochberg, 1995) .
were also identified. Overall, these data strengthen the association 506 between amino acid signatures in V3 and gp41 viral regions, likely 507 implying the contribution of gp41 in the machinery of viral tropism.
508
These results support that the genetic determinants of viral tropism 509 are also inside the gp41, which becomes increasingly important to 510 better understand the viral infection. the T2V V3 and G24T V3 (bootstrap = 1). This cluster was linked to 519 S11S V3 and D25D V3 (bootstrap = 1) (Fig. 3) . Conversely, a large clus-520 ter was found associated with CXCR4-usage. This involves the V3 521 signatures S11GR, 13-14insIG/LG, P16RQ, Q18KR, F20ILV, D25KRQ,
522
and Q32KR, along with the gp41 mutated positions A30T, S107N, 523 D148E, and A189S (bootstrap = 0.86) (Fig. 3) . Overall, our results
524
suggest that specific additional gp41 signatures could be taken to 525 implement the genotypic prediction. to predict co-receptor usage alone or in combination with the V3 534 region. In particular, the A30T gp41 has been postulated to be a criti-
535
cal determinant for co-receptor usage. In our study, the A30T minor 536 variant (1.6% in 312 one sequence/patient) was 100% associated to 537 CXCR4-tropic viruses (Table 2) 
